These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8553874)

  • 1. Vasostatins, N-terminal products of chromogranin A, are released from the stimulated calf spleen in vitro.
    Liang F; Dillen L; Zhang XY; Coen EP; Hogue-Angeletti R; Claeys M; De Potter WP
    Acta Physiol Scand; 1995 Sep; 155(1):23-30. PubMed ID: 8553874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A processing in sympathetic neurons and release of chromogranin A fragments from sheep spleen.
    Miserez B; Annaert W; Dillen L; Aunis D; De Potter W
    FEBS Lett; 1992 Dec; 314(2):122-4. PubMed ID: 1459242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.
    Angeletti RH; Aardal S; Serck-Hanssen G; Gee P; Helle KB
    Acta Physiol Scand; 1994 Sep; 152(1):11-9. PubMed ID: 7810329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve.
    Leitner B; Lovisetti-Scamihorn P; Heilmann J; Striessnig J; Blakely RD; Eiden LE; Winkler H
    J Neurochem; 1999 Mar; 72(3):1110-6. PubMed ID: 10037482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland.
    Helle KB; Marley PD; Angeletti RH; Aunis D; Galindo E; Small DH; Livett BG
    J Neuroendocrinol; 1993 Aug; 5(4):413-20. PubMed ID: 7691355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence and release of the chromogranin B-derived secretolytin-like peptide KR-11 from the porcine spleen.
    Depreitere J; Wang Z; Liang F; Coen E; Nouwen EJ
    Regul Pept; 2004 Oct; 122(2):99-107. PubMed ID: 15380927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of chromogranin A by bovine parathyroid secretory granules: production and secretion of N-terminal fragments.
    Drees BM; Hamilton JW
    Endocrinology; 1994 May; 134(5):2057-63. PubMed ID: 8156905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New biological aspects of chromogranin A-derived peptides: focus on vasostatins.
    Tota B; Quintieri AM; Di Felice V; Cerra MC
    Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):11-8. PubMed ID: 17306579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
    Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
    Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquid chromatography/electrospray mass spectrometry.
    Zhang XY; De Meester I; Lambeir AM; Dillen L; Van Dongen W; Esmans EL; Haemers A; Scharpé S; Claeys M
    J Mass Spectrom; 1999 Apr; 34(4):255-63. PubMed ID: 10226356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of synaptophysin in noradrenergic nerve terminals: a biochemical and morphological study.
    Annaert WG; Llona I; de Ridder E; Weyns A; Quatacker J; de Potter WP
    Synapse; 1995 Sep; 21(1):65-76. PubMed ID: 8525464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) -- evidence of dimer-monomer equilibria.
    Corti A; Sanchez LP; Gasparri A; Curnis F; Longhi R; Brandazza A; Siccardi AG; Sidoli A
    Eur J Biochem; 1997 Sep; 248(3):692-9. PubMed ID: 9342219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural vasostatin-containing peptides in rat heart.
    Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
    FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pig splenic nerve: peptides derived from chromogranins by proteolytic processing during axonal transport.
    Lovisetti-Scamihorn P; Liang F; Leitner B; De Potter W; Winkler H
    Regul Pept; 1999 Jan; 79(1):63-7. PubMed ID: 9930584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine.
    Blois A; Holmsen H; Martino G; Corti A; Metz-Boutigue MH; Helle KB
    Regul Pept; 2006 Mar; 134(1):30-7. PubMed ID: 16445995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A: osmotically active fragments and their susceptibility to proteolysis during lysis of the bovine chromaffin granules.
    Helle KB; Reed RK; Ehrhart M; Aunis D; Hogue Angeletti R
    Acta Physiol Scand; 1990 Apr; 138(4):565-74. PubMed ID: 2191538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery.
    Mandalà M; Brekke JF; Serck-Hanssen G; Metz-Boutigue MH; Helle KB
    Regul Pept; 2005 Jan; 124(1-3):73-80. PubMed ID: 15544843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
    Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
    J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of noradrenaline release from rabbit atria induced by nicotinic agonists.
    Sarantos-Laska C; Majewski H; McCulloch MW; Rand MJ
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):294-305. PubMed ID: 7447568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.